Johnson & Johnson Business Finance Contracts & Agreements

29 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of 3.550% Notes due 2044
Note Agreements
Johnson & Johnson
2024
Form of 3.350% Notes due 2036
Note Agreements
Johnson & Johnson
2024
Form of 3.200% Notes due 2032
Note Agreements
Johnson & Johnson
2024
Company Order establishing the terms of the Euro Notes
Note Agreements
Johnson & Johnson
2024
Form of 5.250% Notes due 2054
Note Agreements
Johnson & Johnson
2024
Form of 4.950% Notes due 2034
Note Agreements
Johnson & Johnson
2024
Form of 4.900% Notes due 2031
Note Agreements
Johnson & Johnson
2024
Form of 4.800% Notes due 2029
Note Agreements
Johnson & Johnson
2024
Company Order establishing the terms of the U.S. Dollar Notes
Note Agreements
Johnson & Johnson
2024
Underwriting Agreement, dated May 14, 2024, among Johnson & Johnson and J.P. Morgan Securities plc, Citigroup Global Markets Limited, Deutsche Bank AG, London Branch and the...
Underwriting Agreements
Johnson & Johnson
2024
Underwriting Agreement Standard Provisions (Debt), dated May 13, 2024
Underwriting Agreements
Johnson & Johnson
2024
Underwriting Agreement, dated May 13, 2024, among Johnson & Johnson and J.P. Morgan Securities LLC, BofA Securities, Inc. and Citigroup Global Markets Inc., as representatives of...
Underwriting Agreements
Johnson & Johnson
2024
Registration Rights Agreement, dated as of May 3, 2023, by and between Johnson & Johnson and Kenvue Inc
Registration Rights Agreements
Johnson & Johnson
2023
Contingent Value Rights Agreement, dated as of December 22, 2022, by and between Johnson & Johnson and American Stock Transfer & Trust Company, LLC
Stock Agreements
Johnson & Johnson
Pharmaceuticals
DE
2022
Company Order establishing the terms of the Notes
Note Agreements
Johnson & Johnson
Pharmaceuticals
2020
Form of Underwriting AgreementStandard Provisions (Debt) dated as of August 20, 2020
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2020
DESCRIPTION OF SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Description of Capital Stock
Stock Agreements
Johnson & Johnson
Pharmaceuticals
NY
2020
Company Order establishing the terms of the Notes
Note Agreements
Johnson & Johnson
Pharmaceuticals
2017
Second Supplemental Indenture dated as of November 9, 2017 between Johnson & Johnson and The Bank of New York Mellon Trust Company, N.A., as trustee
Indenture Agreements
Johnson & Johnson
Pharmaceuticals
NY
2017
Form of Underwriting AgreementStandard Provisions (Debt) dated as of November 8, 2017
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
2017
UNDERWRITING AGREEMENT
Underwriting Agreements
Johnson & Johnson
Pharmaceuticals
NY
2016
[FORM OF FLOATING RATE NOTE]
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2013
JOHNSON & JOHNSON FORM OF CERTIFICATE RESTRICTED SHARE UNIT
Share Agreements
Johnson & Johnson
Pharmaceuticals
2012
JOHNSON & JOHNSON FORM OF CERTIFICATE STOCK OPTION
Stock Agreements
Johnson & Johnson
Pharmaceuticals
2012
JOHNSON & JOHNSON 2000 STOCK OPTION PLAN (Effective April 19, 2000, as amended February 10, 2003 and October 1, 2003)
Stock Agreements
Johnson & Johnson
Pharmaceuticals
2012
JOHNSON & JOHNSON FORM OF CERTIFICATE RESTRICTED SHARE UNIT
Share Agreements
Johnson & Johnson
Pharmaceuticals
2012
JOHNSON & JOHNSON FORM OF CERTIFICATE STOCK OPTION
Stock Agreements
Johnson & Johnson
Pharmaceuticals
2012
$500 million aggregate principal amount of Floating Rate Notes due 2013
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2011
$500 million aggregate principal amount of Floating Rate Notes due 2013
Note Agreements
Johnson & Johnson
Pharmaceuticals
2011